Titlebook: Controversies in the Management of Gynecological Cancers; Jonathan A. Ledermann,Carien L. Creutzberg,Michael Book 2014 Springer-Verlag Lon

prolate

abracadabra

https://doi.org/10.1007/978-94-009-2717-9nhibitors. Chemotherapy continues to be the mainstay in the treatment of endometrial cancer despite the development of these novel agents. In the future, combining chemotherapy with targeted agents shows promise in improving progression-free survival in patients with endometrial cancer.

NAUT

Calibrate

P. T. Tueller (Professor of Range Ecology)rsies regarding the impact of maintenance therapy for treating women with ovarian cancer exist. This chapter details the advantages and disadvantages of continuation medical treatment in newly diagnosed ovarian cancer after primary treatment based on the highest levels of evidence.